Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Oscillation plus lung-expansion therapy to clear mucus and reopen lungs in ventilated patients with atelectasis

Official title: The Efficacy of Oscillation and Lung Expansion (OLE) Therapy Evaluated by Compterized Tomography (CT) and Electrical Impedance Tomography(EIT)in Prolonged Mechanical Ventilated Patients With Atelectasis: A Multicenter Randomized Contralled Trial

Run by Capital Medical University · NCT07451405 · Data updated 2026-11-12

This trial tests whether combining chest oscillation with continuous positive airway pressure and high-frequency oscillation can help adults on prolonged mechanical ventilation with atelectasis clear mucus and re-expand their lungs.

More Atelectasis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorCapital Medical University
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedMarch 15, 2026
Main results expectedApril 1, 2026
Study endsOctober 1, 2026
Registry record updatedMarch 5, 2026
Trial IDNCT07451405 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with prolonged tracheostomy (≥7 days), frequent heavy airway secretions related to pulmonary infection, and stable vital signs are the intended participants.

Probably not a fit

Patients who are hemodynamically unstable, have untreated pneumothorax, very high oxygen requirements (FiO2 > 60%), recent total pneumonectomy, active hemoptysis, pulmonary bullae, delirium, or who cannot tolerate chest oscillation are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study compares a combined oscillation and lung-expansion (OLE) approach—which integrates CPAP, continuous high-frequency oscillation, and external chest oscillation—against high-frequency chest wall oscillation or other standard airway clearance therapies in hospitalized patients. Eligible patients are adults with prolonged tracheostomy (≥7 days) who have frequent, heavy airway secretions and stable vital signs. Outcomes include secretion clearance, lung re-expansion assessed by imaging and electrical impedance tomography, and changes in respiratory parameters and oxygenation. Safety, tolerance, and short-term clinical respiratory outcomes will be monitored during treatment at the respiratory rehabilitation center.

Why it matters

Potential benefit: If successful, OLE could speed mucus clearance and reopen collapsed lung areas, potentially shortening time on the ventilator and improving breathing.

How similar studies have gone: High-frequency chest wall oscillation has prior clinical support for improving secretion clearance, but the combined OLE approach (CPAP plus continuous high-frequency oscillation) is a newer, less-tested integrated technique.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years old
* The following characteristics of high mucus secretion in the airway occur along with pulmonary infection: coughing up a large amount of white sticky phlegm, yellow phlegm or yellow purulent phlegm; Phlegm sounds can be heard in the lungs. The frequency of sputum aspiration is higher than once every 4 hours
* Tracheotomy time ≥7 days
* Vital signs are stable.

Exclusion Criteria:

* Hemodynamic instability
* Inhaled oxygen concentration (FiO2) \> 60%
* Untreated pneumothorax
* Patients who have undergone total pneumonectomy
* Hemoptysis
* Pulmonary bullae, etc.
* Patients with delirium and restlessness

Where it's running

  • Respiratory rehabilitation center
    Beijing, Beijing Municipality, China
    Recruiting
  • Shuo Chen
    Beijing, China
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.